The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.2 Billion by 2028, exhibiting a growth rate (CAGR) of 2.9% during 2023-2028. More Info:- https://www.imarcgroup.com/mrna-vaccines-therapeutics-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global mRNA Vaccines and
Therapeutics Market Research and
Forecast Report 2023-2028
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global mRNA Vaccines and Therapeutics Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled "mRNA Vaccines and Therapeutics Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global
mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022.
Messenger Ribonucleic Acid (mRNA) is a single-stranded RNA molecule that plays a vital role in
human biology, especially in protein synthesis. Numerous mRNA vaccines and therapeutics are now
available in the market that are administered in the human body to trigger virus-detecting immune
sensors. This is executed to induce the production of antibodies that further bind to the potential
pathogens.
These solutions use genetic information to produce viral antigen proteins within the cells and
provide acquired immunity through an RNA containing vector, such as lipid nanoparticles. Their use
aids in boosting the immunity of the body by improving B- and T-cell responses.
Request for a PDF sample of this report: https://www.imarcgroup.com/mrna-vaccines-
therapeutics-market/requestsample

4. Report Description
Report Description and Highlights
Global mRNA Vaccines and Therapeutics Market Trends:
mRNA vaccines represent a promising alternative to conventional vaccines due to their high potency,
capacity for rapid development and potential for low-cost manufacture. Along with this, there has been
a rise in the requirement of vaccines and therapeutics for the treatment of various viral infections, such
as Ebola and Human Immunodeficiency Virus (HIV). Since these therapeutics are considered to be more
effective against pathogens due to their enhanced immunogenicity, numerous private and public
companies are heavily investing in extensive research and development (R&D) activities in the field of
biotechnology for vaccine development and protein replacement therapy using mRNA.
Additionally, on account of the outbreak of the coronavirus disease (COVID-19) pandemic, numerous
companies are currently engaging in the development of a vaccine to curb the transmission of the virus,
thereby creating a positive outlook for the market. Moderna, Inc. is one such leading mRNA technology
firm that is actively invested in the development of the mRNA-1273 vaccine against the novel
coronavirus (SARS-CoV-2). It has registered positive interim results in its Phase 1 study and has already
proceeded with the Phase 3 study of mRNA-1273 that is being conducted in collaboration with the NIH
and BARDA. The market is further driven by the significant improvements in the lipid nanoparticle
formulations for in-vivo systemic delivery of mRNA.

5. Report Description
Report Description and Highlights
Looking forward, IMARC Group expects the market is anticipated to reach a value of US$ 66.2 Billion
by 2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/mrna-vaccines-therapeutics-
market

6. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Vaccine Type:
•Self-amplifying mRNA-Based Vaccines
•Conventional Non-Amplifying mRNA-Based Vaccines
Breakup by Treatment Type:
•Bioengineered Vaccine
•Gene Therapy
•Gene Transcription
•Cell Therapy
•Monoclonal Antibody
•Others
Breakup by Vaccine Manufacturing:
•In-House
•Out-Sourced

7. Report Description
Report Description and Highlights
Breakup by Application:
•Cancer
•Infectious Disease
•Gene Editing
•Protein Replacement
Breakup by End-User:
•Hospitals and Clinics
•Research Organizations
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Arcturus Therapeutics Inc
•BioNTech SE
•CureVac AG
•eTheRNA immunotherapies NV
•ethris GmbH
•GlaxoSmithKline PLC
•Moderna Therapeutics Inc
•Translate Bio Inc
•Argos Therapeutics, Inc
•Sangamo Therapeutics Inc
•Pfizer Inc
•etc

9. Report Description
Key Questions Answered in the Report
1. What was the size of the global mRNA vaccines and therapeutics market in 2022?
2. What is the expected growth rate of the global mRNA vaccines and therapeutics market during
2023-2028?
3. What are the key factors driving the global mRNA vaccines and therapeutics market?
4. What has been the impact of COVID-19 on the global mRNA vaccines and therapeutics market?
5. What is the breakup of the global mRNA vaccines and therapeutics market based on the vaccine
type?
6. What is the breakup of the global mRNA vaccines and therapeutics market based on the
treatment type?
7. What is the breakup of the global mRNA vaccines and therapeutics market based on vaccine
manufacturing?
8. What is the breakup of the global mRNA vaccines and therapeutics market based on the
application?
9. What is the breakup of the global mRNA vaccines and therapeutics market based on the end-
user?
10. What are the key regions in the global mRNA vaccines and therapeutics market?
11. Who are the key players/companies in the global mRNA vaccines and therapeutics market?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Introduction to mRNA Vaccines and Therapeutics
5.1 History of mRNA Vaccines and Therapeutics Development
5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases
5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics
5.3.1 mRNA Modifications

11. Report Description Table of Contents
5.3.2 mRNA Efficiencies
5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines
5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics
6 Global mRNA Vaccines and Therapeutics Market
6.1 Market Potential Overview
6.2 Market Potential
6.3 Impact of COVID-19
6.4 mRNA Vaccines in Pipeline
7 Market Breakup by Vaccine Type
7.1 Self-amplifying mRNA-Based Vaccines
7.2 Conventional Non-Amplifying mRNA-Based Vaccines
8 Market Breakup by Treatment Type
8.1 Gene Therapy
8.2 Monoclonal Antibody
8.3 Gene Transcription
8.4 Cell Therapy
8.5 Bioengineered Vaccine
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/mrna-vaccines-therapeutics-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us